si
Earlier this week, the Texas Rangers made a significant roster move, sending infielder Josh Smith to the Toronto Blue Jays in exchange for left-handed reliever Adam Macko. The trade signals a shift in the Rangers' infield plans, as Smith had become expendable amid a slump and the emergence of other players.
Smith, who once seemed destined to be a cornerstone for Texas, had a breakout 2024 season, earning the AL Silver Slugger for utility players. However, his performance dipped notably this year, with a slash line of .213/.299/.272. The Rangers also saw the rise of Ezequiel Duran and dealt with injuries and illness, making Smith the odd man out.
Trade Analysis
The Blue Jays are acquiring a versatile player with a career slash line of .234/.325/.346, 32 home runs, and 136 RBIs. Smith's on-base skills and defensive flexibility make him a valuable asset, though his role in Toronto remains uncertain, possibly depending on deadline moves. He has two more years of control and motivation to prove himself.
Macko, a former top-30 prospect for Toronto, brings a promising two-pitch arsenal to the Rangers' bullpen. In 22 innings this season, he has a 4.91 ERA with 23 strikeouts and 10 walks. His slider, thrown 41% of the time, averages 85.3 mph, while his fastball sits at 94.5 mph. Statcast data shows a high whiff rate of 32.8% and solid exit velocity numbers, suggesting he can be an effective setup man.
The Rangers also included pitching prospect Josh Stephan in the deal, which some analysts view as an unnecessary sweetener. Overall, the trade grades as a B- for Texas, as they add a controllable lefty to a bullpen that already features Jacob Latz and Robby Ahlstrom.